- Country: India
Zydus launches in U.S. MSN Labs generic of Bayer’s PAH drug
The two companies are the first to launch the product, which is a generic version of Bayer’s Adempas.
The two companies are the first to launch the product, which is a generic version of Bayer’s Adempas.
First-to-market launch brings a lower-cost riociguat to U.S. patients living with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension AHMEDABAD, India and PENNINGTON, N.J., Oct. 5, 2026 /PRNewswire/ -- Zydus Lifesciences Limited (Zydus), in partnership with...
PETALING JAYA: Persatuan sukan yang meraih pingat emas pada Sukan Asia Aichi-Nagoya 2026 boleh menarik nafas lega apabila Majlis Sukan Negara (MSN) memberi jaminan untuk mempertimbangkan peruntukan tambahan bagi memastikan momentum kecemerlangan mereka terus diperkukuhkan. Ketua Pengarah MSN, Jefri…